Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Maybe de sellers ran out of shares

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Aug 24, 2023 5:41pm

167 Views

Post# 35604488

RE:RE:RE:Maybe de sellers ran out of shares

Another day holding above $1 during a down market day with no big selloffs ;->
Feels like we are at slack tide now waiting for the next high tide to come back in, anyone else feel the same?
I have bought some small amounts the last two days and have one more couch left to scour for change to put into the Thera slot machine tomorrow....GO THERA!

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023